# UPDATE: All Eyes on Allergan: Drug Company’s Unprecedented Move Raises Questions for Patent and Drug Law (Part I)
> **Legal Sidebar** · 2018-03-16 · `LSB10009`
## Report
- **CRS ID:** LSB10009
- **Series:** Legal Sidebar
- **Publication date:** 2018-03-16
## Documents
- [PDF](https://www.everycrsreport.com/files/2018-03-16_LSB10009_bd4e65f214f33ced2d60fe2d238e532888396bd3.pdf)
- [HTML](https://www.everycrsreport.com/files/2018-03-16_LSB10009_bd4e65f214f33ced2d60fe2d238e532888396bd3.html)
---
*AI Analytics · CC0 1.0*